📰 Seqone Genomics News
Seqone Genomics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Seqone Genomics. Real-time updates on events, politics, business and more.
March 14, 2023
A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion SeqOne Genomics,
October 4, 2022
Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform
April 22, 2022
/PRNewswire/ -- The AI in genomics market is expected to reach $19,596.2 million by 2030 from an estimated $519.0 million in 2021, at a CAGR of 49.7% from 2021...
April 22, 2022
/PRNewswire/ -- The AI in genomics market is expected to reach $19,596.2 million by 2030 from an estimated $519.0 million in 2021, at a CAGR of 49.7% from 2021...
February 14, 2022
The company plans to use the funds to focus on the oncology space.
February 3, 2022
The study will compare Illumina's TruSight Oncology 500 assay to the standard of care for therapy selection in up to 400 cancer patients.
January 28, 2022
Earlier this week, the tech giant IBM sold off chunks of its once-promising artificial intelligence (AI)-guided division Watson Health. Despite this setback, European firms see a bright future for the use of AI in healthcare.
January 27, 2022
The French startup targets leadership in personalised medicine with high-performance genomic analysis.
January 26, 2022
The French company SeqOne Genomics has raised €20M in a Series A round as growing investments reach startups delivering the next generation of genomics and bioinformatics.
January 24, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!